Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune channelopathies.

Camilla Buckley1, Angela Vincent

  • 1University of Oxford, UK.

Nature Clinical Practice. Neurology
|August 26, 2006
PubMed
Summary
This summary is machine-generated.

Autoimmune disorders affecting the neuromuscular junction and central nervous system (CNS) are increasingly linked to specific antibodies. Detecting these antibodies aids in diagnosing and managing conditions like myasthenia gravis and autonomic neuropathy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Immunotherapy responsive startle with antibodies to voltage gated potassium channels.

BMJ case reports·2025
Same author

Subtype-specific atypical B cell profiles in myasthenia gravis reveal distinct immunopathological pathways.

Frontiers in immunology·2025
Same author

Evolution and significance of neuronal surface autoantibodies after Japanese encephalitis.

Journal of neuroimmunology·2025
Same author

GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice.

Journal of neurology·2025
Same journal

Methylphenidate improves cognitive function during rehabilitation after TBI.

Nature clinical practice. Neurology·2010
Same journal

Parkinson disease assessment feasible with an at-home testing device.

Nature clinical practice. Neurology·2010
Same journal

Somatosensory cortex reorganization linked to neuropathic pain.

Nature clinical practice. Neurology·2010
Same journal

Gene variants linked to atrial fibrillation are also associated with risk of ischemic stroke.

Nature clinical practice. Neurology·2010
Same journal

Skin impedance is a potential marker for Fabry disease.

Nature clinical practice. Neurology·2010
Same journal

Glioblastoma produces tumor-promoting microvesicles.

Nature clinical practice. Neurology·2010
See all related articles

Area of Science:

  • Neuroimmunology
  • Autoimmunity
  • Neurology

Background:

  • Autoimmune disorders of the neuromuscular junction, such as myasthenia gravis, have long been associated with autoantibodies targeting acetylcholine receptors.
  • Recent research indicates a growing role for antibodies in central nervous system (CNS) disorders, challenging established concepts of the blood-brain barrier.

Purpose of the Study:

  • To review the role of antibodies targeting receptors and ion channels in both peripheral and central nervous systems.
  • To focus on newly identified autonomic and CNS conditions mediated by antibodies.
  • To highlight the significance of antibody measurement in the diagnosis and management of these neurological disorders.

Main Methods:

  • Review of existing literature on antibody-mediated neurological disorders.

Related Experiment Videos

  • Analysis of the role of autoantibodies in myasthenia gravis, autonomic neuropathies, and emerging CNS conditions.
  • Discussion of diagnostic approaches involving antibody detection and therapeutic implications.

    • Main Results:

    • Established antibody targets include acetylcholine receptors, ligand-gated receptors, voltage-gated ion channels, and related proteins in the peripheral nervous system.
    • Antibodies to ganglionic acetylcholine receptors are linked to autoimmune autonomic neuropathies.
    • Emerging evidence suggests antibody involvement in CNS disorders, with many patients responding to immunosuppressive therapy.

    Conclusions:

    • Antibodies play a critical role in a spectrum of neurological disorders affecting both the peripheral and central nervous systems.
    • The detection of specific antibodies is crucial for diagnosis and guides the use of immunosuppressive therapies.
    • Further research is needed to fully elucidate the mechanisms and therapeutic targets in antibody-mediated CNS diseases.